Public-Private Value Target opportunities that align NIH priorities with private sector capabilities, highlighting FNIH’s niche in funding high-risk, long-term translational research and public health initiatives that may lack private funding or traditional public funding avenues.

Cancer Vaccines Partnership Leverage the recent collaboration with the National Cancer Institute on a $200M public-private cancer vaccine initiative to propose scalable co-funding, clinical trial support, and biomarker-driven study design services.

Liver Disease Initiatives Position offerings around the Biomarkers Consortium’s liver disease diagnostics and treatments projects to supply accelerated R&D, clinical assay development, and regulatory-grade data generation capabilities.

Alumni Network Engagement Use the NIH Alumni Network expansion as a channel to re-engage former collaborators and philanthropic networks for targeted fundraising, joint programs, and sponsorship opportunities.

Financial Leadership With a new Chief Financial Officer and a substantial revenue base, present financial governance, grant management, and impact reporting services tailored for large-scale NIH-aligned programs and public-private partnerships.